Strateos Overview
- Founded
- 2019
- Status
- Private
- Employees
- 87
- Latest Deal Type
- Series B
- Latest Deal Amount
- $56.1M
- Investors
- 16
Strateos General Information
Description
Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The company's platform automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs, enabling pharmaceutical partners to rapidly and efficiently discover new drug candidates.
Contact Information
Website
www.strateos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Enterprise Systems (Healthcare)
Biotechnology
Primary Office
- 3565 Haven Avenue
- Suite 3
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Strateos Timeline
Strateos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 08-Jun-2021 | $56.1M | 000.00 | 00000 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A) | 03-Jun-2019 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Seed Round | $13M | $13M | 0000 | Completed | Startup | |
| 1. Merger of Equals | 03-Jun-2019 | Completed | Startup |
Strateos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A3 | 0,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Seed 2 | 7,260,466 | $0.000100 | $0.09 | $1.18 | $1.18 | 1x | $1.18 | 13.31% |
| Seed 1 | 4,190,792 | $0.000100 | $0.09 | $1.11 | $1.11 | 1x | $1.11 | 7.68% |
Strateos Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Fischer-Colbrie | President & Chief Executive Officer | ||
| Christopher Krueger | Chief Financial Officer |
Strateos Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Armen Vidian | DCVC | Board Member | 000 0000 |
| Jeffrey Finer Ph.D | Self | Chairman | 000 0000 |
| Joshua Wolfe | Lux Capital Management | Board Member | 000 0000 |
| Mara Aspinall | Self | Vice Chairman | 000 0000 |
Strateos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialStrateos Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ally Bridge Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Alumni Ventures Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Black Diamond Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Eli Lilly | Corporation | Minority | 000 0000 | 000000 0 | |
| Harmonix Fund | Venture Capital | Minority | 000 0000 | 000000 0 |
Strateos Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 | 03-Jun-2019 | 000000000000000000 | Laboratory Services (Healthcare) | ||
| 3Scan | 26-Apr-2019 | Merger/Acquisition | Diagnostic Equipment |